Finally, our results demonstrated that targeted inhibition of BRIX1 by therapeutic exosomes efficiently enhanced 5‐FU chemotherapy and suppressed the growth of colorectal cancer with wild‐type p53 (Figure 7; Figure S5, Supporting Information). Here, BRIX1 is linked to colorectal cancer.